Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic development

<p>Abstract</p> <p>Background</p> <p>The presence of functional 5-HT<sub>4 </sub>receptors in human and its involvement in neonatal lupus erythematosus (NLE) have prompted us to study the receptor expression and role during embryogenesis. Earlier we managed...

Full description

Bibliographic Details
Main Authors: Muller Sylviane, Fischmeister Rodolphe, Garcia Simone, Lezoualc'h Frank, Kamel Rehab, Hoebeke Johan, Eftekhari Pierre
Format: Article
Language:English
Published: BMC 2007-04-01
Series:BMC Developmental Biology
Online Access:http://www.biomedcentral.com/1471-213X/7/34
id doaj-baefeebf4dcf424da53399adef44a493
record_format Article
spelling doaj-baefeebf4dcf424da53399adef44a4932020-11-24T20:53:40ZengBMCBMC Developmental Biology1471-213X2007-04-01713410.1186/1471-213X-7-34Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic developmentMuller SylvianeFischmeister RodolpheGarcia SimoneLezoualc'h FrankKamel RehabHoebeke JohanEftekhari Pierre<p>Abstract</p> <p>Background</p> <p>The presence of functional 5-HT<sub>4 </sub>receptors in human and its involvement in neonatal lupus erythematosus (NLE) have prompted us to study the receptor expression and role during embryogenesis. Earlier we managed to demonstrate that female BALB/c mice immunized against the second extracellular loop (SEL) of the 5-HT<sub>4 </sub>receptor gave birth to pups with heart block. To explain this phenomenon we investigated the expression of 5-HT<sub>4 </sub>receptors during mouse embryogenesis. At the same time we looked whether the consequence of 5-HT<sub>4 </sub>receptor immunomodulation observed earlier is in relation to receptor expression.</p> <p>We studied the expression of 5-HT<sub>4 </sub>receptor at the mRNA level and its two isoforms 5-HT<sub>4(a) </sub>and 5-HT<sub>4(d) </sub>at the protein level in embryos from BALB/c mice, at 8<sup>th</sup>, 12<sup>th</sup>, 18<sup>th </sup>gestation days (GD) and 1 day post natal (DPN). Simultaneously the receptor activity was inhibited by rising antibodies, in female mice against SEL of the receptor. The mice were mated and embryos were collected at 8<sup>th</sup>, 12<sup>th</sup>, 18<sup>th </sup>GD and 1 DPN.</p> <p>Results</p> <p>5-HT<sub>4 </sub>receptor mRNA increased in brain from 12<sup>th </sup>GD to 1 DPN. Its expression gradually decreased in heart and disappeared at birth. This was consistent with expression of the receptor isoforms 5-HT<sub>4(a) and (d)</sub>. Abnormalities like decreased number of embryos, growth delay, spina bifida and sinus arrhythmia from 12<sup>th </sup>GD were documented in pups of mice showing anti-5-HT<sub>4 </sub>receptor antibodies.</p> <p>Conclusion</p> <p>serotoninergic 5-HT<sub>4 </sub>receptor plays an important role in mouse foetal development. In BALB/c mice there is a direct relation between the expression of receptor and the deleterious effect of maternal anti-5-HT<sub>4 </sub>receptor autoantibodies in early embryogenesis.</p> http://www.biomedcentral.com/1471-213X/7/34
collection DOAJ
language English
format Article
sources DOAJ
author Muller Sylviane
Fischmeister Rodolphe
Garcia Simone
Lezoualc'h Frank
Kamel Rehab
Hoebeke Johan
Eftekhari Pierre
spellingShingle Muller Sylviane
Fischmeister Rodolphe
Garcia Simone
Lezoualc'h Frank
Kamel Rehab
Hoebeke Johan
Eftekhari Pierre
Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic development
BMC Developmental Biology
author_facet Muller Sylviane
Fischmeister Rodolphe
Garcia Simone
Lezoualc'h Frank
Kamel Rehab
Hoebeke Johan
Eftekhari Pierre
author_sort Muller Sylviane
title Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic development
title_short Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic development
title_full Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic development
title_fullStr Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic development
title_full_unstemmed Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT<sub>4 </sub>receptor and its consequences in early BALB/c mouse embryonic development
title_sort immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-ht<sub>4 </sub>receptor and its consequences in early balb/c mouse embryonic development
publisher BMC
series BMC Developmental Biology
issn 1471-213X
publishDate 2007-04-01
description <p>Abstract</p> <p>Background</p> <p>The presence of functional 5-HT<sub>4 </sub>receptors in human and its involvement in neonatal lupus erythematosus (NLE) have prompted us to study the receptor expression and role during embryogenesis. Earlier we managed to demonstrate that female BALB/c mice immunized against the second extracellular loop (SEL) of the 5-HT<sub>4 </sub>receptor gave birth to pups with heart block. To explain this phenomenon we investigated the expression of 5-HT<sub>4 </sub>receptors during mouse embryogenesis. At the same time we looked whether the consequence of 5-HT<sub>4 </sub>receptor immunomodulation observed earlier is in relation to receptor expression.</p> <p>We studied the expression of 5-HT<sub>4 </sub>receptor at the mRNA level and its two isoforms 5-HT<sub>4(a) </sub>and 5-HT<sub>4(d) </sub>at the protein level in embryos from BALB/c mice, at 8<sup>th</sup>, 12<sup>th</sup>, 18<sup>th </sup>gestation days (GD) and 1 day post natal (DPN). Simultaneously the receptor activity was inhibited by rising antibodies, in female mice against SEL of the receptor. The mice were mated and embryos were collected at 8<sup>th</sup>, 12<sup>th</sup>, 18<sup>th </sup>GD and 1 DPN.</p> <p>Results</p> <p>5-HT<sub>4 </sub>receptor mRNA increased in brain from 12<sup>th </sup>GD to 1 DPN. Its expression gradually decreased in heart and disappeared at birth. This was consistent with expression of the receptor isoforms 5-HT<sub>4(a) and (d)</sub>. Abnormalities like decreased number of embryos, growth delay, spina bifida and sinus arrhythmia from 12<sup>th </sup>GD were documented in pups of mice showing anti-5-HT<sub>4 </sub>receptor antibodies.</p> <p>Conclusion</p> <p>serotoninergic 5-HT<sub>4 </sub>receptor plays an important role in mouse foetal development. In BALB/c mice there is a direct relation between the expression of receptor and the deleterious effect of maternal anti-5-HT<sub>4 </sub>receptor autoantibodies in early embryogenesis.</p>
url http://www.biomedcentral.com/1471-213X/7/34
work_keys_str_mv AT mullersylviane immunomodulationbymaternalautoantibodiesofthefetalserotoninergic5htsub4subreceptoranditsconsequencesinearlybalbcmouseembryonicdevelopment
AT fischmeisterrodolphe immunomodulationbymaternalautoantibodiesofthefetalserotoninergic5htsub4subreceptoranditsconsequencesinearlybalbcmouseembryonicdevelopment
AT garciasimone immunomodulationbymaternalautoantibodiesofthefetalserotoninergic5htsub4subreceptoranditsconsequencesinearlybalbcmouseembryonicdevelopment
AT lezoualchfrank immunomodulationbymaternalautoantibodiesofthefetalserotoninergic5htsub4subreceptoranditsconsequencesinearlybalbcmouseembryonicdevelopment
AT kamelrehab immunomodulationbymaternalautoantibodiesofthefetalserotoninergic5htsub4subreceptoranditsconsequencesinearlybalbcmouseembryonicdevelopment
AT hoebekejohan immunomodulationbymaternalautoantibodiesofthefetalserotoninergic5htsub4subreceptoranditsconsequencesinearlybalbcmouseembryonicdevelopment
AT eftekharipierre immunomodulationbymaternalautoantibodiesofthefetalserotoninergic5htsub4subreceptoranditsconsequencesinearlybalbcmouseembryonicdevelopment
_version_ 1716796550179454976